As of 2026-05-20, the Fair Value of Fulcrum Therapeutics Inc (FULC) is -4.30 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.91 USD, the upside of Fulcrum Therapeutics Inc is -172.69%.
With the market price of 5.91 USD and our fair value calculation, Fulcrum Therapeutics Inc (FULC) is not a good investment. Investing in FULC stocks now will result in a potential loss of 172.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -80.85 | -109.87 | -97.33 | -9.73 | -74.88 | -74.53 |
| YoY growth | -14.16% | -35.89% | 11.41% | 90.01% | -669.97% | -123.72% |
| Market Cap (mil) | 393.61 |
| P/E | |
| Forward P/E |
| EPS | -0.86 |
| Avg earnings growth rate | -123.72% |
| TTM earnings | -57.23 |